pharmacovigilance

Open Access
Drug-induced Aseptic Meningitis: Pharmacovigilance Analysis of Japanese Adverse Event Reporting Database
SHO MASAGO, KAZUMASA KOTAKE, KENTA YAMAOKA, KENNOSUKE YORIFUJI and TADASHI SHIMIZU

In Vivo March 2026, 40 (2) 1220-1227; DOI: https://doi.org/10.21873/invivo.14277
Open Access
Comprehensive Analysis of Proteinuria and Nephrotic Syndrome Using the Japanese Adverse Drug Event Reporting Database
SHO MASAGO, KENTA YAMAOKA, MAYAKO UCHIDA, YOSHIHIRO UESAWA, KENNOSUKE YORIFUJI and TADASHI SHIMIZU

In Vivo July 2025, 39 (4) 2073-2084; DOI: https://doi.org/10.21873/invivo.14002
Open Access
Vonoprazan-associated Microscopic Colitis and Continued Use After Onset: A Study Using a Japanese Pharmacovigilance Database
KOTA NAKANISHI, YUICHI UWAI and TOMOHIRO NABEKURA

In Vivo July 2025, 39 (4) 2363-2370; DOI: https://doi.org/10.21873/invivo.14034
Open Access
A Time-varying Analysis of General Practice Prescribing in the COVID-19 Era: Lessons from Prescription Dynamics in a Pandemic
KINAN MOKBEL, KATE EMBLIN, ROB DANIELS, FAHAD ALGHAMDI and LEIGH JACKSON

In Vivo January 2025, 39 (1) 498-508; DOI: https://doi.org/10.21873/invivo.13854
Open Access
Association of Antiviral Drugs for the Treatment of COVID-19 With Acute Renal Failure
MASAHIRO KAMO, RINTARO SOGAWA and CHISATO SHIMANOE

In Vivo July 2024, 38 (4) 1841-1846; DOI: https://doi.org/10.21873/invivo.13637
You have access
A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England
KINAN MOKBEL, ROB DANIELS, MICHAEL N. WEEDON and LEIGH JACKSON

In Vivo March 2022, 36 (2) 780-800; DOI: https://doi.org/10.21873/invivo.12765

Main menu

User menu

Search

pharmacovigilance